European drinks group skid after US surgeon general calls for cancer warnings

(Reuters) – Shares in European spirits makers and brewers fell on Friday after the U.S. surgeon general called for cancer warnings on alcoholic drinks. Alcoholic drinks should carry a label warning consumers about their cancer risks, U.S. Surgeon General Vivek Murthy said in an advisory, noting that their consumption increases the risk of developing breast,…

Read More

Musk donated $108 million in Tesla shares to unnamed charities, filing shows

(Reuters) – Tesla chief executive Elon Musk donated 268,000 Tesla shares to unnamed charities just before the new year, according to a regulatory filing on Tuesday. Musk, who owns about 12.8% of Tesla, made the donation as part of his “year-end tax planning” to “certain charities” that have “no current intention to sell such stock,”…

Read More

OpenAI outlines new for-profit structure in bid to stay ahead in costly AI race

By Aditya Soni, Arsheeya Bajwa, Krystal Hu (Reuters) -OpenAI on Friday outlined plans to revamp its structure, saying it would create a public benefit corporation to make it easier to “raise more capital than we’d imagined,” and remove the restrictions imposed on the startup by its current nonprofit parent.  The acknowledgement and detailed rationale behind…

Read More

Nvidia closes $700 million Run:ai acquisition after regulatory hurdles

(Reuters) – Chipmaker Nvidia has completed its acquisition of Israeli AI firm Run:ai, the startup said on Monday, following antitrust scrutiny over the buyout. The European Commission granted unconditional approval to Nvidia’s $700 million bid for Run:ai, which helps developers optimize infrastructure for AI, earlier in December after saying in October that the deal would…

Read More

OpenAI outlines new for-profit structure in bid to stay ahead in costly AI race

By Aditya Soni, Arsheeya Bajwa, Krystal Hu (Reuters) -OpenAI on Friday outlined plans to revamp its structure, saying it would create a public benefit corporation to make it easier to “raise more capital than we’d imagined,” and remove the restrictions imposed on the startup by its current nonprofit parent.  The acknowledgement and detailed rationale behind…

Read More

Retail investors buy Novo dip after disappointing weight-loss drug data

By Bhanvi Satija (Reuters) – U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker’s weaker-than-expected obesity drug data offered a rare dip-buying opportunity, according to Vanda Research. Daily net flows climbed to $15.6 million from $0.49 million a day earlier, after eagerly anticipated data showed Novo’s experimental drug,…

Read More